U.S. markets closed
  • S&P Futures

    4,531.75
    -4.75 (-0.10%)
     
  • Dow Futures

    35,527.00
    -30.00 (-0.08%)
     
  • Nasdaq Futures

    15,327.25
    -13.75 (-0.09%)
     
  • Russell 2000 Futures

    2,285.70
    -3.10 (-0.14%)
     
  • Crude Oil

    84.22
    +0.46 (+0.55%)
     
  • Gold

    1,796.90
    +0.60 (+0.03%)
     
  • Silver

    24.49
    +0.04 (+0.15%)
     
  • EUR/USD

    1.1650
    +0.0004 (+0.03%)
     
  • 10-Yr Bond

    1.6550
    -0.0210 (-1.25%)
     
  • Vix

    15.43
    +0.42 (+2.80%)
     
  • GBP/USD

    1.3773
    +0.0013 (+0.10%)
     
  • USD/JPY

    113.6960
    +0.2360 (+0.21%)
     
  • BTC-USD

    61,576.61
    +445.93 (+0.73%)
     
  • CMC Crypto 200

    1,453.34
    -49.70 (-3.31%)
     
  • FTSE 100

    7,204.55
    +14.25 (+0.20%)
     
  • Nikkei 225

    28,583.92
    -220.93 (-0.77%)
     

FDA’s Call on Lilly’s Covid Drug Is Lifting a Partner’s Beaten-Down Stock

·3 min read
FDA’s Call on Lilly’s Covid Drug Is Lifting a Partner’s Beaten-Down Stock
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

The agency is allowing Lilly's product to be used as a prophylaxis in people who have been exposed to the virus.